SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB THERAPY IN CLINICAL PRACTICE: EFFICACY AND SAFETY IN INFLAMMATORY BOWEL DISEASE

Berta Caballol Oliva  1     Agnès Fernández-Clotet  1     Julian Panés  1     Maica Masamunt Estrella  1     Marta Gallego  1     Rebeca Barastegui  1     Àlex Vara  1     Angel Giner  1     Elena Ricart  1     Ingrid Ordás  1    
1 Hospital Clínic i Provincial de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and CIBEREHD, Barcelona, Spain

Session
Investigator studies in IBD II (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing